Change - Announcement of Cessation::Change - Announcement of Cessation

Issuer & Securities

Issuer/ Manager
THOMSON MEDICAL GROUP LIMITED
Securities
THOMSON MED S$120M5.5%N280531 - SGXF52537366 - V2AB
THOMSON MED S$175M4.05%N250128 - SGXF89249654 - RMEB
THOMSON MEDICAL GROUP LIMITED - SG1M49904634 - A50
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
09-Nov-2023 19:52:07
Status
New
Announcement Sub Title
Change - Announcement of Cessation
Announcement Reference
SG231109OTHR68TH
Submitted By (Co./ Ind. Name)
Dr Heng Jun Li Melvin
Designation
Executive Director and Group CEO
Description (Please provide a detailed description of the event in the box below)
Cessation of Ms Wan Nadiah Binti Wan Mohd Abdullah Yaakob as Executive Director of the Company

Additional Details

Name Of Person
Wan Nadiah Binti Wan Mohd Abdullah Yaakob
Age
39
Is effective date of cessation known?
Yes
If yes, please provide the date
09/11/2023
Detailed Reason (s) for cessation
Ms Wan Nadiah is the Executive Director and Group CEO of TMC Life Sciences Berhad, the Group's multi-disciplinary healthcare subsidiary listed on Bursa Malaysia. She has resigned from the Board of the Company to focus her time and commitment on the opening of the new beds for the expansion wing at Thomson Hospital Kota Damansara and growing of the Group's Malaysian business.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of Appointment to current position
01/01/2022
Does the AC have a minimum of 3 members (taking into account this cessation)?
No
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
4
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
2
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Executive Director of the Company
Role and responsibilities
Ms Wan Nadiah will continue in her role as the Executive Director and Group CEO of TMC Life Sciences Berhad.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
None.
Shareholding interest in the listed issuer and its subsidiaries?
No
Past (for the last 5 years)
Nil
Present
- BB Waterfront Sdn. Bhd.
- Institute of Corporate Directors Malaysia
- IVF Technologies Sdn. Bhd.
- Skies VB Sdn. Bhd.
- Thomson Hospital Sdn. Bhd.
- TMC Biotech Sdn. Bhd.
- TMC Care Sdn. Bhd.
- TMC Life Sciences Berhad
- TMC Lifestyle Sdn. Bhd.
- TMC Properties Sdn. Bhd.
- Thomson TCM Sdn. Bhd.
- TMC Women s Specialist Holdings Sdn. Bhd.
- Vantage Bay JB Sdn. Bhd.